- Altria filed a lawsuit against the FDA, arguing that the current premarket review system has stifled growth for tobacco companies in the U.S. market.
- The lawsuit targets what Altria describes as a slow, antiquated approval process and represents the latest industry challenge to the FDA’s review system.